BDraganov
TL2 Member · Augsburg, DE
Based in the EU. Tracks what is available and funded locally, and dates every claim.
Joined 22 January 2025 · last posted 3h · groups: regional-eu
88 posts, newest first. Showing up to 150.
-
Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #3 · Practice › Administration · 28 Jul 2026 · 14 likes Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
-
What changed in 2026, by region — does this still hold? Replied, post #26 · Access › International · 27 Jul 2026 · 14 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #98 · Nutrition & Training › Protein & intake · 23 Jul 2026 · 27 likes Worth stating the null on Protein density versus volume before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #85 · Access › Insurance & coverage · 20 Jul 2026 · 0 likes A clinician's supporting letter that addresses the criteria explicitly is worth considerably more than one that describes the patient generally. Two sources, same…
-
What a certificate commits its issuer to Replied, post #43 · Analytics › COA interpretation · 16 Jul 2026 · 1 like Where I part company with post #41, and it is a narrow parting. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #30 · Practice › Dosing & titration · 16 Jul 2026 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. Concentration and dose get conflated constantly in this subcategory. Changing how much…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #46 · Practice › Interactions · 15 Jul 2026 · 7 likes Post #44 describes the usual case. This is about the unusual one. Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #40 · Start Here › Welcome · 15 Jul 2026 · 23 likes Understood. Thank you for being specific about the limits of it.
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 14 Jul 2026 · 4 likes Cagrilintide alone is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #99 · Evidence › Journal club · 12 Jul 2026 · 30 likes Confirming post #96 from a second method, which matters more than confirming it from a second person. The version of SURMOUNT-OSA that circulates here is a…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #124 · Sourcing › Logistics · 5 Jul 2026 · 0 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #68 · Compounds › Oral incretins · 1 Jul 2026 · 32 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Conditions that change the calculus rather than forbidding it Replied, post #26 · Safety › Contraindications · 30 Jun 2026 · 18 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. The short answer was in the first…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #86 · Practice › Administration · 28 Jun 2026 · 1 like Narrowing post #85, because the general version has more than one answer. Letting a refrigerated preparation come to room temperature before injecting reduces the sting…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #20 · Evidence › Meta-analyses · 28 Jun 2026 · 15 likes Genuine question rather than a rhetorical one: has anyone here actually observed Risk-of-bias tools, as opposed to read about it? The thread is long and I cannot tell.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #42 · Sourcing › Independent verification · 25 Jun 2026 · 33 likes A supplier's own certificate is not independent. It can be posted, it is useful, and it is labelled for what it is.
-
Pooling trials with different estimands Replied, post #44 · Evidence › Meta-analyses · 23 Jun 2026 · 17 likes Where I have landed on pooling trials with different estimands, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a…
-
GLP-1 receptor distribution: central and peripheral Replied, post #70 · Pharmacology › Receptor biology · 15 Jun 2026 · 0 likes Receptor occupancy required for a clinical effect is not the same as full occupancy, and dose-response curves flattening at the top is what you would expect from that.…
-
Private prescribing in the UK: what is actually involved Replied, post #35 · Regional › UK & Ireland · 10 Jun 2026 · 0 likes The claim about private prescribing upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #38 · Clinical › Special populations · 3 Jun 2026 · 13 likes Filing a mild objection to the consensus on bariatric surgery history. Mild because I might be wrong; an objection because nobody has addressed the case that does not…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #43 · Pharmacology › Pharmacokinetics · 2 Jun 2026 · 0 likes Confirming post #42 from a second method, which matters more than confirming it from a second person. Accumulation at steady state: with a week-long half-life,…
-
Bioimpedance and hydration: why the number moves Replied, post #46 · Outcomes › Body composition · 17 May 2026 · 0 likes What would change my mind on bioimpedance and hydration is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #22 · Analytics › Home & field testing · 15 May 2026 · 0 likes I had written a reply contradicting post #18 and deleted it. Here is what survived. False positives and false negatives: no test has 100% sensitivity and 100%…
-
The best-written scientific paper you have read Replied, post #46 · Lounge › Off topic · 14 May 2026 · 18 likes Analytics first, in my case, and I still find the practice category the harder read. Chromatography has one right answer more often than logistics does. That matches…
-
Private prescribing in the UK: what is actually involved Replied, post #6 · Regional › UK & Ireland · 29 Apr 2026 · 0 likes Private prescribing is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Reading a home test result without over-claiming Replied, post #15 · Analytics › Home & field testing · 17 Apr 2026 · 11 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #2 · Devices › Syringes & needles · 31 Mar 2026 · 0 likes Everything in the opening post holds. The case it does not cover is the one I have. U-100 means the barrel is graduated for a solution containing one hundred units of…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #7 · Compounds › Retatrutide · 15 Mar 2026 · 0 likes This follows post #6 rather than contradicting it. Counterpoint on TRIUMPH, offered without confidence: the same observation is consistent with a much duller…
-
Preservatives: function, testing, and limits — one year on Replied, post #3 · Pharmacology › Formulation chemistry · 6 Mar 2026 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #14 · Analytics › HPLC & UHPLC · 3 Mar 2026 · 1 like Appreciated. The plain phrasing does more work here than a longer post would.
-
[2026 update] Composite endpoints and the component doing the work Replied, post #17 · Evidence › Trials · 2 Mar 2026 · 6 likes Post #15 describes the usual case. This is about the unusual one. Where I have landed on Composite endpoints, having got it wrong once in public: the direction is…
-
Managing an unplanned gap in supply Replied, post #36 · Access › Shortages · 19 Feb 2026 · 24 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another. I have written this out at length because the short…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #29 · Compounds › Semaglutide · 17 Feb 2026 · 17 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Journal club: LEADER as the historical anchor Replied, post #35 · Evidence › Journal club · 15 Feb 2026 · 3 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #4 · Analytics › Impurities & related substances · 8 Feb 2026 · 22 likes This follows post #3 rather than contradicting it. That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot exclude…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #63 · Regional › UK & Ireland · 13 Jan 2026 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #65 · Sourcing › Independent verification · 2 Jan 2026 · 2 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #5 · Sourcing › Vendor reports · 29 Dec 2025 · 0 likes Confirming post #4 from a second method, which matters more than confirming it from a second person. Comparing your result to somebody else's on a different lot is not…
-
Tracking a preprint to publication: a worked example Replied, post #147 · Evidence › Preprints · 14 Dec 2025 · 32 likes Post #144 is right about the mechanism and I think understates the practical bit. Always label it as a preprint in any discussion. A preprint is not a published trial…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #45 · Compounds › Tirzepatide · 11 Nov 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #15 · Practice › Side effects · 11 Nov 2025 · 5 likes Building on post #12 rather than restating it. Careful with the language on Dizziness on standing. "Not detected" and "not present" are different findings and the first…
-
Managing an unplanned gap in supply — what changed since Replied, post #113 · Access › Shortages · 11 Nov 2025 · 12 likes Two sentences on Managing an unplanned gap and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow.…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #30 · Compounds › Semaglutide · 2 Nov 2025 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #60 · Compounds › Tirzepatide · 30 Oct 2025 · 10 likes Practical answer on dual agonism, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #12 · Practice › Storage & stability · 17 Oct 2025 · 10 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #26 · Safety › Adverse events · 16 Oct 2025 · 5 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
Reading an interaction checker output critically Replied, post #17 · Practice › Interactions · 6 Oct 2025 · 0 likes Practical answer on reading an interaction checker output, since the theoretical one is upthread: do the simplest check first, write down the result, and only then…
-
The headache that turns out to be dehydration Replied, post #11 · Nutrition & Training › Hydration & electrolytes · 1 Oct 2025 · 9 likes Post #9 answers the question as asked. The question underneath it is different. Symptoms attributed to electrolytes here are non-specific and overlap with dehydration,…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #8 · Research Methods › N-of-1 designs · 28 Sep 2025 · 25 likes Building on post #7 rather than restating it. Committing to post the result before you know it is a useful precommitment, and this subcategory is a reasonable place to…
-
High-resolution MS on aggregates and what it can see Replied, post #61 · Analytics › Mass spectrometry · 6 Sep 2025 · 12 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
A comparison of home results against a laboratory result on the same vial Replied, post #33 · Analytics › Home & field testing · 5 Sep 2025 · 1 like Anything that changes colour is measuring a reaction, and reactions have interferents. A positive result in the presence of an excipient you did not expect is not…
-
Specification in the result column: why that is a meaningful error Replied, post #37 · Analytics › COA interpretation · 29 Aug 2025 · 12 likes Worth separating two things that post #35 runs together. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough…
-
When to stop reading forums, including this one Replied, post #17 · Wellbeing › Mental health · 21 Aug 2025 · 25 likes The social side of this — how other people respond to visible change — comes up constantly and has nothing to do with pharmacology.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #55 · Compounds › Retatrutide · 19 Aug 2025 · 15 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
System suitability injections: if they failed, the run did not happen Replied, post #21 · Analytics › HPLC & UHPLC · 9 Aug 2025 · 23 likes Post #19 answers the question as asked. The question underneath it is different. Summarising the system suitability injections thread so far, since it is long and the…
-
A ten-fold dose error caught before injection — one year on Replied, post #127 · Devices › Syringes & needles · 4 Aug 2025 · 0 likes What I want from this ten-fold dose error caught thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check…
-
Canadian access and provincial variation — one year on Replied, post #29 · Regional › North America · 25 Jul 2025 · 11 likes If you are new and reading this thread for the answer to Canadian access and provincial variation: the answer is conditional, the conditions are in the third reply, and…
-
About the Trials category Replied, post #10 · Evidence › Trials · 20 Jul 2025 · 28 likes Picking up post #7: that is the part I would want checked first. Absolute and relative effects answer different questions. Write down the event rate in each arm and the…
-
Substitution between formats during a shortage Replied, post #13 · Access › Shortages · 23 Jun 2025 · 0 likes Worth separating two things that post #11 runs together. The practical version of substitution between formats is three sentences long. The rigorous version is three…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #137 · Compounds › Cagrilintide & amylin analogues · 18 Jun 2025 · 5 likes Worth separating two things that post #135 runs together. The practical version of CagriSema phase 2 paper is three sentences long. The rigorous version is three pages…
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #15 · Sourcing › Payments · 16 Jun 2025 · 33 likes Adding a small correction to the Payment mechanics summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #13 · Sourcing › Vendor reports · 16 Jun 2025 · 0 likes Post #12 put the caveat in the right place and I want to underline it. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #9 · Analytics › Mass spectrometry · 21 May 2025 · 0 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
-
Follow-up: What other technical communities get right that we do not Replied, post #103 · Lounge › Off topic · 19 May 2025 · 31 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Pages past their review date, listed — does this still hold? Replied, post #14 · Meta › Wiki maintenance · 7 May 2025 · 3 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
What a 2 ppm match establishes, and what it does not Replied, post #16 · Analytics › Mass spectrometry · 6 May 2025 · 9 likes Post #13 is right about the mechanism and I think understates the practical bit. Positional isomers and epimers are mass-identical. Any argument that a mass result…
-
Telehealth prescribing models in the US Replied, post #90 · Regional › North America · 26 Apr 2025 · 14 likes The documentation on telehealth prescribing models is better than this thread and I say that as someone who has posted in the thread.
-
Scheduled maintenance and what will be unavailable Replied, post #109 · Meta › Announcements · 14 Apr 2025 · 23 likes Reading rather than answering, but this is the post I would point somebody at.
-
Review cadence: how often is a page actually re-checked? Replied, post #12 · Documentation › Doc review · 8 Apr 2025 · 0 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
Transit times by route, from a logged dataset — the long version Replied, post #78 · Sourcing › Logistics · 4 Apr 2025 · 1 like Agreed on Transit times, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #32 · Practice › Reconstitution · 3 Apr 2025 · 11 likes Post #28 put the caveat in the right place and I want to underline it. On 10 mg vial reconstituted three the community has more anecdote than the confidence in this…
-
Charge states for a 4 kDa peptide, worked through Replied, post #143 · Analytics › Mass spectrometry · 18 Mar 2025 · 0 likes I had written a reply contradicting post #139 and deleted it. Here is what survived. Mass accuracy is expressed in parts per million. It is the difference between…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #63 · Wellbeing › Mental health · 18 Mar 2025 · 0 likes Taking post #60 at face value and following it one step further. My experience of anxiety contradicts the reply above. I am posting it as a data point rather than as a…
-
Reading a chromatogram someone posted without axes Replied, post #11 · Analytics › HPLC & UHPLC · 15 Mar 2025 · 32 likes Following this. I have the same question and no better information than the first post.
-
Coming back to: Official shortage notices and what they authorise Replied, post #34 · Access › Shortages · 22 Feb 2025 · 21 likes I had written a reply contradicting post #32 and deleted it. Here is what survived. Where an alternative within the class is available, the comparison is a clinical one…
-
SNAC and the mechanism of oral peptide absorption Replied, post #7 · Compounds › Oral incretins · 19 Feb 2025 · 11 likes Post #5 is the version of this I will quote in future. One addition. Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip…
-
A promotion I argued against, and why I lost Replied, post #101 · Documentation › Doc review · 17 Feb 2025 · 3 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. Anyone with a larger sample, please…
-
Protein density versus volume when you cannot eat much Replied, post #50 · Nutrition & Training › Protein & intake · 1 Feb 2025 · 8 likes Post #48 and I disagree about the size of the effect, not about the direction. Renal considerations around higher protein intake apply to people with existing renal…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #115 · Access › Insurance & coverage · 11 Jan 2025 · 0 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept. One of those cases where knowing the mechanism does not help…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #35 · Practice › Side effects · 18 Dec 2024 · 0 likes If someone has run nausea timeline properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
What changed in 2026, by region Replied, post #22 · Access › International · 14 Dec 2024 · 1 like Where a compound is approved under a different trade name in another market, searching the local name finds documents the English name does not.
-
Two sessions a week versus four: what the evidence supports Started this topic · Nutrition & Training › Resistance training · 8 Nov 2024 · 23 likes On the subject in the title: Two sessions a week versus four: what the evidence supports Working notes rather than a conclusion. Reporting rather than asking, and the…
-
Time to steady state after a dose increase Replied, post #40 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 5 likes Dose proportionality across the studied range means dose arithmetic behaves the way you would naively expect. It is worth checking whether it holds for a given compound…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #62 · Clinical › Comorbidities · 19 Oct 2024 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #53 · Clinical › Prescriber conversations · 8 Sep 2024 · 27 likes Nothing here is medical advice, and this subcategory exists to help people ask better questions rather than to answer them.
-
Correlation in a self-tracked dataset: what it can support Replied, post #136 · Research Methods › Statistics · 25 Aug 2024 · 9 likes Building on post #133 rather than restating it. Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders.…
-
Chronic kidney disease and the FLOW result Replied, post #19 · Clinical › Comorbidities · 16 Aug 2024 · 3 likes Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it.
-
Journal club: FLOW and the renal composite, component by component Replied, post #21 · Evidence › Journal club · 10 Jul 2024 · 2 likes Post #20 is right about the mechanism and I think understates the practical bit. The baseline characteristics table is the single most useful page for the questions…